Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hemophilia treatment in 2021: Choosing the"optimal" treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians.
Hermans C, Noone D, Benson G, Dolan G, Eichler H, Jiménez-Yuste V, Königs C, Lobet S, Pollard D, Zupančić-Šalek S, Mancuso ME. Hermans C, et al. Among authors: zupancic salek s. Blood Rev. 2022 Mar;52:100890. doi: 10.1016/j.blre.2021.100890. Epub 2021 Sep 29. Blood Rev. 2022. PMID: 34736780 Free article. Review.
Haemophilia B: Where are we now and what does the future hold?
Dolan G, Benson G, Duffy A, Hermans C, Jiménez-Yuste V, Lambert T, Ljung R, Morfini M, Zupančić Šalek S. Dolan G, et al. Blood Rev. 2018 Jan;32(1):52-60. doi: 10.1016/j.blre.2017.08.007. Epub 2017 Aug 16. Blood Rev. 2018. PMID: 28826659 Review.
Tailoring care to haemophilia patients' needs: which specialty and when?
Morfini M, Benson G, Jiménez-Yuste V, Ljung R, Mannucci PM, Pasta G, Remor E, Zupančić Šalek S. Morfini M, et al. Blood Transfus. 2015 Oct;13(4):644-50. doi: 10.2450/2015.0302-14. Epub 2015 May 20. Blood Transfus. 2015. PMID: 26057493 Free PMC article. No abstract available.
Outcome measures for adult and pediatric hemophilia patients with inhibitors.
Hermans C, Auerswald G, Benson G, Dolan G, Duffy A, Jiménez-Yuste V, Ljung R, Morfini M, Lambert T, Osooli M, Zupančić Šalek S. Hermans C, et al. Eur J Haematol. 2017 Aug;99(2):103-111. doi: 10.1111/ejh.12881. Epub 2017 Apr 25. Eur J Haematol. 2017. PMID: 28332238 Review.
Practical aspects of extended half-life products for the treatment of haemophilia.
Lambert T, Benson G, Dolan G, Hermans C, Jiménez-Yuste V, Ljung R, Morfini M, Zupančić-Šalek S, Santagostino E. Lambert T, et al. Ther Adv Hematol. 2018 Sep 6;9(9):295-308. doi: 10.1177/2040620718796429. eCollection 2018 Sep. Ther Adv Hematol. 2018. PMID: 30210757 Free PMC article. Review.
Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors.
Shapiro AD, Angchaisuksiri P, Astermark J, Benson G, Castaman G, Eichler H, Jiménez-Yuste V, Kavakli K, Matsushita T, Poulsen LH, Wheeler AP, Young G, Zupančić-Šalek S, Oldenburg J, Chowdary P. Shapiro AD, et al. Among authors: zupancic salek s. Blood Adv. 2022 Jun 14;6(11):3422-3432. doi: 10.1182/bloodadvances.2021006403. Blood Adv. 2022. PMID: 35290453 Free PMC article.
57 results